A Systematic Literature Review of Brain Volume Loss and Disability or Cognition Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis

被引：0
|
作者：
Benjumea, D. [1 ]
Janeczko, P. [1 ]
Callahan, P. [1 ]
Amari, D. [1 ]
Silva, D. [2 ]
Tencer, T. [2 ]
机构：
[1] Genesis Res, Hoboken, NJ USA
[2] Bristol Myers Squibb, Summit, NJ USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO3199
引用
收藏
页码：1138 / 1138
页数：1
相关论文
共 50 条
  • [41] Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple Sclerosis
    Merlo, Daniel
    Stankovich, Jim
    Bai, Claire
    Kalincik, Tomas
    Zhu, Chao
    Gresle, Melissa
    Lechner-Scott, Jeannette
    Kilpatrick, Trevor
    Barnett, Michael
    Taylor, Bruce
    Darby, David
    Butzkueven, Helmut
    Van der Walt, Anneke
    NEUROLOGY, 2021, 97 (20) : E2020 - E2031
  • [42] The association between disease activity and disability progression in patients with relapsing-remitting multiple sclerosis
    Spelman, T.
    Geale, K.
    Anell, B.
    Hillert, J.
    Wong, S. L.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 127 - 128
  • [43] Cognitive impairment in relapsing-remitting multiple sclerosis patients
    Altinkaya, A.
    Ozcan, E.
    Yandim-Kuscu, D.
    Kurt, E.
    Bingol, A.
    Kirbas, D.
    Topcular, B.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 406 - 406
  • [44] MICROBIOME CORE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Navarro-Lopez, V.
    Mingot, J. M.
    Carrion-Gutierrez, M.
    Paya-Espinosa, Y.
    Ruzafa Costa, B.
    Nunez Delegido, E.
    ANNALS OF NUTRITION AND METABOLISM, 2018, 72 : 56 - 57
  • [45] Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
    Onder, Halil
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (02) : 105 - 106
  • [46] The prognostic value of initial relapses on the evolution of disability in patients with relapsing-remitting multiple sclerosis
    Binquet, C.
    Quantin, C.
    Le Teuff, G.
    Pagliano, J. F.
    Abrahamowicz, M.
    Moreau, T.
    NEUROEPIDEMIOLOGY, 2006, 27 (01) : 45 - 54
  • [47] Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis
    Gonzalez, Miguel Llaneza
    Rueda, Pedro Carrascal
    Sanchez, Olga Delgado
    Guerra, Monica Borges
    Antiguedad, Alfredo Rodriguez
    Baladron, Alberto Morell
    Rios, Noelia Becerril
    Rovira, Alex
    Lallana, Virgina Meca
    Benedito-Palos, Laura
    Comellas, Marta
    Vilanova, David
    Echeto, Ainara
    Perez, Xavier
    Oreja-Guevara, Celia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 84
  • [48] Prevalence of disability improvement in relapsing-remitting multiple sclerosis patients treated with cladribine tablets
    Signori, Alessio
    Ponzano, Marta
    Alexandri, Nektaria
    Giovannoni, Gavin
    Sormani, Maria Pia
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (07) : 2144 - 2147
  • [49] Clinical predictors of disability in treatment-naive relapsing-remitting multiple sclerosis patients
    Ivaniuk, A.
    Solodovnikova, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 921 - 921
  • [50] Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability
    Migliore, S.
    Ghazaryan, A.
    Simonelli, I.
    Pasqualetti, P.
    Squitieri, F.
    Curcio, G.
    Landi, D.
    Palmieri, M. G.
    Moffa, F.
    Filippi, M. M.
    Vernieri, F.
    BEHAVIOURAL NEUROLOGY, 2017, 2017
12345